Mark Rolfe serves as Executive at FACET BIOTECH CORP, where they oversee executive responsibilities. Since joining the company, Mark Rolfe has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 21, 2010 involved selling 21,333 shares valued at $576.0K.
Mark Rolfe currently holds 21,333 shares of FACET BIOTECH CORP (FACT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Rolfe has been a net neutral trader of FACT stock. They have purchased $0 and sold $0 worth of shares.
Mark Rolfe's most recent insider trade was on Apr 21, 2010, when they sold 21,333 shares at $27.00 per share.
Get notified when new Form 4 filings are submitted
| 1,113 |
| $27.00 |
| Discretionary |
| Aug 20, 2009 | FACT | $0 | Award | 21,333 | $N/A | Discretionary |